advertisement

---

Lu F 9

Showing records 1 to 9 | Display all abstracts from Lu F

90564 Intraocular pressure-lowering effect of omidenepag isopropyl in latanoprost non-/low-responder patients with primary open-angle glaucoma or ocular hypertension: the FUJI study
Aihara M
Japanese Journal of Ophthalmology 2020; 64: 398-406

---

90210 Omidenepag Isopropyl Versus Latanoprost in Primary Open-Angle Glaucoma and Ocular Hypertension: The Phase 3 AYAME Study
Aihara M; Lu F
American Journal of Ophthalmology 2020; 220: 53-63

---

90564 Intraocular pressure-lowering effect of omidenepag isopropyl in latanoprost non-/low-responder patients with primary open-angle glaucoma or ocular hypertension: the FUJI study
Ropo A; Lu F
Japanese Journal of Ophthalmology 2020; 64: 398-406

---

90210 Omidenepag Isopropyl Versus Latanoprost in Primary Open-Angle Glaucoma and Ocular Hypertension: The Phase 3 AYAME Study
Kawata H
American Journal of Ophthalmology 2020; 220: 53-63

---

90564 Intraocular pressure-lowering effect of omidenepag isopropyl in latanoprost non-/low-responder patients with primary open-angle glaucoma or ocular hypertension: the FUJI study
Kawata H
Japanese Journal of Ophthalmology 2020; 64: 398-406

---

90210 Omidenepag Isopropyl Versus Latanoprost in Primary Open-Angle Glaucoma and Ocular Hypertension: The Phase 3 AYAME Study
Iwata A; Odani-Kawabata N
American Journal of Ophthalmology 2020; 220: 53-63

---

90564 Intraocular pressure-lowering effect of omidenepag isopropyl in latanoprost non-/low-responder patients with primary open-angle glaucoma or ocular hypertension: the FUJI study
Iwata A; Odani-Kawabata N
Japanese Journal of Ophthalmology 2020; 64: 398-406

---

90210 Omidenepag Isopropyl Versus Latanoprost in Primary Open-Angle Glaucoma and Ocular Hypertension: The Phase 3 AYAME Study
Shams NK
American Journal of Ophthalmology 2020; 220: 53-63

---

90564 Intraocular pressure-lowering effect of omidenepag isopropyl in latanoprost non-/low-responder patients with primary open-angle glaucoma or ocular hypertension: the FUJI study
Shams N
Japanese Journal of Ophthalmology 2020; 64: 398-406

---